Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Pulmonology · Pulmonary Mycobacterium avium Complex Disease

What Tests Diagnose Pulmonary MAC If I Can't Produce Sputum?

At a Glance

If you cannot produce sputum, pulmonary MAC can be evaluated with supervised sputum induction or bronchoscopy. Induced sputum usually requires two positive cultures, while one positive sample collected during bronchoscopy may meet criteria when symptoms and chest imaging fit MAC.

In this answer

3 sections

01

Clinician-Supervised Sputum Induction

02

Bronchoscopy

03

Meeting the Diagnostic Criteria and What to Expect

If you have symptoms and chest imaging suggestive of pulmonary Mycobacterium avium complex (MAC), your doctor will need a sample of your lung secretions to confirm the diagnosis. Difficulty producing sputum on your own is very common, especially if you have a non-productive cough, and it is not a failure on your part. To help get a sample, your doctor will likely recommend sputum induction or a bronchoscopy.

Because a MAC diagnosis requires identifying the specific bacteria in your lungs, these tests are used to safely collect a sample for the lab. While a standard sputum test requires at least two positive cultures from separately collected sputum samples, only one positive culture is needed if the sample is a bronchial wash or bronchoalveolar lavage (BAL) collected during a bronchoscopy, provided your symptoms and chest imaging also fit MAC [1][2].

Clinician-Supervised Sputum Induction

Sputum induction is a non-invasive, outpatient procedure where a respiratory therapist or nurse helps you produce sputum [3]. You will inhale a mist of hypertonic saline (a strong saltwater solution) through a nebulizer. This helps thin the mucus in your lungs and stimulates a cough.

  • What it shows: The sample is sent for an acid-fast bacillus (AFB) smear (a rapid microscopic test that detects mycobacteria but doesn’t identify the exact species) and a mycobacterial culture (growing the bacteria to identify it specifically as MAC) [3][4]. Because this is still treated as a sputum sample, you generally need positive cultures from at least two separate induction procedures to meet the diagnostic criteria for MAC [1][5].
  • Practical risks: Sputum induction is generally safe but can cause bronchospasm (temporary airway narrowing), chest tightness, and a temporary drop in oxygen levels [6][7]. For this reason, it must be performed under clinical supervision with appropriate monitoring, and never attempted unsupervised at home [7][8]. Sometimes, a bronchodilator (like albuterol) is given beforehand to prevent airway spasms [6].

Bronchoscopy

If sputum induction is unsuccessful, unavailable, or negative despite strong suspicion of MAC, your doctor may recommend a bronchoscopy [9][3]. This is a more invasive procedure generally performed under sedation. A pulmonologist guides a thin, flexible tube with a camera (a bronchoscope) into your airways to examine them and collect fluid samples [10].

During the procedure, the doctor will flush sterile saline into the airways and suction it back up. There are two main ways to do this:

  • Bronchial wash: Samples the larger airways [11].
  • Bronchoalveolar lavage (BAL): Pushes fluid deeper into the smaller air sacs before collecting it [12].

Both methods have comparable diagnostic yields (how often they successfully detect MAC). Some studies show BAL is particularly sensitive for patients with the nodular-bronchiectatic form of the disease (a pattern on a CT scan showing widened airways and small lung nodules) [11][3].

Lung Biopsy: A lung biopsy (taking a small piece of tissue) is not a routine part of a bronchoscopy for MAC. It is usually only done if your doctor needs to rule out other conditions like cancer or severe inflammation, or if less invasive tests are inconclusive [13].

Practical risks: Bronchoscopy carries risks such as temporary hypoxemia (low oxygen levels), post-procedure fever, cough, and wheezing [14][15]. If a biopsy is added, there is an increased risk of bleeding or a pneumothorax (collapsed lung) [16]. Your doctor will evaluate your respiratory reserve (how well your lungs can handle the procedure) and bleeding risk beforehand [13][17].

Preparation and Recovery: You will likely need to fast before the procedure and arrange for someone to drive you home due to sedation. Do not stop taking blood thinners or other medications unless explicitly instructed by your doctor. After the procedure, seek urgent medical care if you experience severe shortness of breath, significant chest pain, coughing up large amounts of blood, or a persistent high fever. A mild sore throat or low-grade fever can be common short-term effects, but ask your care team when you should call them.

Meeting the Diagnostic Criteria and What to Expect

Diagnosing MAC requires a combination of symptoms, compatible chest imaging, and microbiologic evidence, while ruling out other causes like tuberculosis [18][19].

  • Bronchoscopy Criteria: Just one positive culture from a bronchial wash or BAL satisfies the microbiologic criteria for pulmonary MAC [1][2].
  • Biopsy Criteria: If a biopsy is taken, it meets the criteria if the tissue shows specific microscopic signs of mycobacterial infection (like granulomas) and the culture is positive for MAC, or if the tissue shows these signs and a separate respiratory sample is positive [20].
  • Contamination vs. Infection: Keep in mind that finding MAC in your lungs does not automatically mean you have active disease or need immediate antibiotics [21]. MAC is common in the environment, and it could just be colonizing your airways without causing harm. Your doctor will determine if treatment is necessary based on your symptoms, disease pattern, and progression risk.

Testing Timeline: An AFB smear result may come back in a few days, but a negative smear does not completely rule out MAC. Mycobacterial cultures grow very slowly; it can take several weeks to grow and identify the exact MAC species, and even longer to test which antibiotics will work best (susceptibility testing).

Common questions in this guide

What can test for pulmonary MAC if I cannot produce sputum?
Your clinician may first use sputum induction, in which you inhale a saline mist to help bring up mucus for testing. If that does not work, is unavailable, or suspicion remains high, bronchoscopy can collect a bronchial wash or bronchoalveolar lavage sample from the airways.
What does sputum induction involve, and is it safe?
During supervised sputum induction, a nebulizer delivers hypertonic saline to thin mucus and trigger a cough. It is generally safe, but can cause temporary airway narrowing, chest tightness, or lower oxygen levels, so it should be done in a clinic with monitoring and not at home.
Do I need a bronchoscopy to diagnose MAC if induced sputum is negative?
Not always, but your doctor may recommend bronchoscopy if sputum induction is unsuccessful, unavailable, or negative despite strong symptoms and imaging findings. Bronchoscopy can collect a bronchial wash or bronchoalveolar lavage sample for testing and culture, and it is performed with sedation and its own procedure risks.
How many positive samples are needed to confirm pulmonary MAC?
With separately collected sputum samples, diagnostic criteria generally require positive cultures from at least two samples along with compatible symptoms and chest imaging. A single positive culture from a bronchial wash or bronchoalveolar lavage may satisfy the microbiologic requirement when the clinical and imaging findings fit pulmonary MAC.
How long does testing for pulmonary MAC take?
An acid-fast bacillus smear may be available within a few days, but a mycobacterial culture can take several weeks because MAC grows slowly. Identifying the species and testing which antibiotics are likely to work can take additional time, and a negative smear does not completely rule out MAC.
Does a positive MAC culture mean I need treatment?
Not necessarily. MAC can be present in the airways without causing active disease, so your clinician considers your symptoms, chest imaging, culture results, and risk of progression before recommending observation or antibiotics.
Is a lung biopsy usually needed to diagnose pulmonary MAC?
Usually not. A biopsy may be considered when less invasive tests are inconclusive or when doctors need to rule out cancer or severe inflammation; if performed, tissue findings and culture results are interpreted together with respiratory samples.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my symptoms and CT scan, do you recommend trying sputum induction first, or should we go straight to a bronchoscopy?
  2. 2.If we do a bronchoscopy, will you be taking a lung biopsy, and if so, why is it necessary?
  3. 3.How will the results of this test change our decision to observe my condition versus starting treatment?
  4. 4.Have tuberculosis and other potential causes of my CT findings been fully excluded?
  5. 5.If the induced sputum or bronchoscopy sample comes back negative, what is our next step?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Pulmonary MAC Cause Lasting Lung Damage or Shorten Life?Can Gardening Expose You to Mycobacterium avium Complex?Can You Have Pulmonary MAC With a Negative AFB Smear?Does an AFB-Positive Sputum Test Mean I Have Tuberculosis?Does a Positive MAC Sputum Culture Always Mean Lung Disease?How Do Doctors Tell if Pulmonary MAC Treatment Is Working?Why Isn't Pulmonary MAC Contagious to Your Family?How Often Are CT Scans and Breathing Tests Used for MAC?How Quickly Does Untreated Pulmonary MAC Disease Progress?How Should I Collect Sputum for Pulmonary MAC Diagnosis?Is MAC After Culture Conversion a Relapse or Reinfection?Should I Get Immune or Lung Testing for Pulmonary MAC?What Do CT Scan Findings Mean in Pulmonary MAC Disease?What Factors Affect Your Chances of Clearing Pulmonary MAC?What Follow-Up Is Needed After Pulmonary MAC Treatment?What Tests Check for Disseminated MAC Outside the Lungs?What Water Precautions Are Recommended for MAC Lung Disease?When Is Watchful Waiting Appropriate for Pulmonary MAC?Why Do MAC Species ID and Macrolide Testing Matter?

References

References (21)
  1. 1

    Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study.

    Kim HJ, Lee JH, Yoon SH, et al.

    BMC infectious diseases 2019; (19(1)):468 doi:10.1186/s12879-019-4078-0.

    PMID: 31126235
  2. 2

    Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.

    Daley CL, Winthrop KL

    The Journal of infectious diseases 2020; (222(Suppl 4)):S199-S211 doi:10.1093/infdis/jiaa354.

    PMID: 32814943
  3. 3

    Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease.

    Licata MA, Mencarini P, Mastrobattista A, et al.

    Pathogens (Basel, Switzerland) 2024; (13(12)) doi:10.3390/pathogens13121064.

    PMID: 39770324
  4. 4

    Fluorescent microscopy and Ziehl-Neelsen staining of bronchoalveolar lavage, bronchial washings, bronchoscopic brushing and post bronchoscopic sputum along with cytological examination in cases of suspected tuberculosis.

    Bodal VK, Bal MS, Bhagat S, et al.

    Indian journal of pathology & microbiology 2015; (58(4)):443-7 doi:10.4103/0377-4929.168849.

    PMID: 26549064
  5. 5

    The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody.

    Kawasaki T, Kitada S, Fukushima K, et al.

    Microbiology spectrum 2022; (10(1)):e0140621 doi:10.1128/spectrum.01406-21.

    PMID: 34985326
  6. 6

    Benefits of three consecutive sputum inductions using nebulized racemic salbutamol versus hypertonic saline in smear-negative or sputum-scarce pulmonary tuberculosis patients: a prospective randomized, double-blind study.

    Keeratichananont W, Keeratichananont S, Ubonsutvanich N, Chaisurote J

    Microbiology spectrum 2026; (14(8)):e0058126 doi:10.1128/spectrum.00581-26.

    PMID: 42390245
  7. 7

    Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio-sampling of the lower airways in children and adults.

    Schultz A, Balaguruswamy S, Dentice R, et al.

    Respirology (Carlton, Vic.) 2024; (29(5)):372-378 doi:10.1111/resp.14707.

    PMID: 38556839
  8. 8

    Safety and yield of sputum induction for diagnosis of pulmonary tuberculosis in children in a tertiary hospital in Ghana.

    Owusu KS, Kwarteng-Owusu S, Wireko-Brobby N, et al.

    African journal of thoracic and critical care medicine 2024; (30(4)):e1841 doi:10.7196/AJTCCM.2024.v30i4.1841.

    PMID: 40041416
  9. 9

    Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease.

    Shimada D, Sagawa M, Seki M

    Infection and drug resistance 2023; (16()):977-984 doi:10.2147/IDR.S400200.

    PMID: 36824065
  10. 10

    Characteristics of patients with bronchoscopy-diagnosed pulmonary Mycobacterium avium complex infection.

    Urabe N, Sakamoto S, Sano G, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2018; (24(10)):822-827 doi:10.1016/j.jiac.2018.06.014.

    PMID: 30054229
  11. 11

    Usefulness of bronchial sputum aspirate specimens for the diagnosis of Non-tuberculous mycobacterial pulmonary disease.

    Urabe N, Sakamoto S, Tokita N, et al.

    Respiratory investigation 2025; (63(1)):174-179 doi:10.1016/j.resinv.2024.12.015.

    PMID: 39733741
  12. 12

    The diagnostic yield and characteristics of bronchoalveolar lavage in suspected nontuberculous mycobacterial pulmonary disease.

    Kajikawa S, Fujishiro E, Kato T, et al.

    International journal of mycobacteriology 2022; (11(3)):236-240 doi:10.4103/ijmy.ijmy_77_22.

    PMID: 36260440
  13. 13

    Impact of antimicrobial exposure on bronchoscopy yields in immunocompromised patients: a single-centre experience.

    Teng A, Tan D, Saripalli KR, et al.

    Journal of thoracic disease 2026; (18(4)):327 doi:10.21037/jtd-2025-1-2783.

    PMID: 42182674
  14. 14

    Diagnostic value of bronchoalveolar lavage and bronchial washing in sputum-scarce or smear-negative cases with suspected pulmonary tuberculosis: a randomized study.

    Kim YW, Kwon BS, Lim SY, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020; (26(7)):911-916 doi:10.1016/j.cmi.2019.11.013.

    PMID: 31759097
  15. 15

    Pediatric flexible and rigid bronchoscopy in European centers-Availability and current practice.

    Schramm D, Yu Y, Wiemers A, et al.

    Pediatric pulmonology 2017; (52(11)):1502-1508 doi:10.1002/ppul.23823.

    PMID: 28910517
  16. 16

    Tissue sample taken by transbronchial biopsy in the diagnosis of tuberculosis; benefits-risks.

    Rabahoğlu B, Tutar N, Baran B, et al.

    Lung India : official organ of Indian Chest Society 2025; (42(5)):438-442 doi:10.4103/lungindia.lungindia_653_24.

    PMID: 40892816
  17. 17

    Flexible Bronchoscopy in a Patient With Pneumomediastinum and Hypoxemic Respiratory Failure: High-Flow Nasal Cannula to the Rescue.

    Pb S, Hadda V, Madan K, et al.

    Cureus 2021; (13(1)):e12800 doi:10.7759/cureus.12800.

    PMID: 33628669
  18. 18

    Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease.

    Griffith DE, Aksamit TR

    Clinics in chest medicine 2023; (44(4)):757-769 doi:10.1016/j.ccm.2023.07.003.

    PMID: 37890914
  19. 19

    Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates.

    Ghio AJ, Smith GS, DeFlorio-Barker S, et al.

    Journal of clinical tuberculosis and other mycobacterial diseases 2019; (17()):100133 doi:10.1016/j.jctube.2019.100133.

    PMID: 31867444
  20. 20

    Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease.

    Yan M, Brode SK, Marras TK

    Clinics in chest medicine 2023; (44(4)):799-813 doi:10.1016/j.ccm.2023.06.011.

    PMID: 37890917
  21. 21

    Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.

    Schiff HF, Jones S, Achaiah A, et al.

    Scientific reports 2019; (9(1)):1730 doi:10.1038/s41598-018-37350-8.

    PMID: 30741969

This page describes testing options for suspected pulmonary MAC when sputum is difficult to produce. It is for informational purposes only and does not constitute medical advice; your pulmonologist or treating clinician can recommend the safest test for your situation.

Get notified when new evidence is published on Mycobacterium avium complex disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.